Nintedanib 150 MG [Ofev]
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
PureTech
Overview
Nintedanib 150 MG [Ofev] is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Nintedanib 150 MG [Ofev] clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nintedanib 150 MG [Ofev] for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.